FR2322592B1 - - Google Patents

Info

Publication number
FR2322592B1
FR2322592B1 FR7626461A FR7626461A FR2322592B1 FR 2322592 B1 FR2322592 B1 FR 2322592B1 FR 7626461 A FR7626461 A FR 7626461A FR 7626461 A FR7626461 A FR 7626461A FR 2322592 B1 FR2322592 B1 FR 2322592B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7626461A
Other languages
French (fr)
Other versions
FR2322592A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of FR2322592A1 publication Critical patent/FR2322592A1/fr
Application granted granted Critical
Publication of FR2322592B1 publication Critical patent/FR2322592B1/fr
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/76Nitrogen atoms to which a second hetero atom is attached
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/42One nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/69Benzenesulfonamido-pyrimidines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/22Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
    • C07D295/26Sulfur atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
FR7626461A 1975-09-02 1976-09-02 Nouveaux sulfonamides, leur preparation et leur application comme medicaments Granted FR2322592A1 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CH1136675 1975-09-02
CH1136775 1975-09-02
CH1419475 1975-11-04
CH21876 1976-01-09

Publications (2)

Publication Number Publication Date
FR2322592A1 FR2322592A1 (fr) 1977-04-01
FR2322592B1 true FR2322592B1 (US20100268047A1-20101021-C00003.png) 1978-11-17

Family

ID=27427797

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7626461A Granted FR2322592A1 (fr) 1975-09-02 1976-09-02 Nouveaux sulfonamides, leur preparation et leur application comme medicaments

Country Status (11)

Country Link
JP (1) JPS5233645A (US20100268047A1-20101021-C00003.png)
AU (1) AU1737376A (US20100268047A1-20101021-C00003.png)
DE (1) DE2637882A1 (US20100268047A1-20101021-C00003.png)
DK (1) DK380176A (US20100268047A1-20101021-C00003.png)
ES (1) ES451113A1 (US20100268047A1-20101021-C00003.png)
FI (1) FI762419A (US20100268047A1-20101021-C00003.png)
FR (1) FR2322592A1 (US20100268047A1-20101021-C00003.png)
IL (1) IL50390A0 (US20100268047A1-20101021-C00003.png)
NO (1) NO762922L (US20100268047A1-20101021-C00003.png)
PT (1) PT65538B (US20100268047A1-20101021-C00003.png)
SE (1) SE7609494L (US20100268047A1-20101021-C00003.png)

Also Published As

Publication number Publication date
FI762419A (US20100268047A1-20101021-C00003.png) 1977-03-03
ES451113A1 (es) 1977-11-16
NO762922L (US20100268047A1-20101021-C00003.png) 1977-03-03
SE7609494L (sv) 1977-03-03
DK380176A (da) 1977-03-03
AU1737376A (en) 1978-03-09
FR2322592A1 (fr) 1977-04-01
JPS5233645A (en) 1977-03-14
IL50390A0 (en) 1976-10-31
PT65538B (fr) 1978-05-10
DE2637882A1 (de) 1977-03-03
PT65538A (fr) 1976-09-01

Similar Documents

Publication Publication Date Title
FR2322592B1 (US20100268047A1-20101021-C00003.png)
CH592717A5 (US20100268047A1-20101021-C00003.png)
BG22358A1 (US20100268047A1-20101021-C00003.png)
BG21720A1 (US20100268047A1-20101021-C00003.png)
BG21777A1 (US20100268047A1-20101021-C00003.png)
BG22239A1 (US20100268047A1-20101021-C00003.png)
BG22265A1 (US20100268047A1-20101021-C00003.png)
CH596048A5 (US20100268047A1-20101021-C00003.png)
BG22707A1 (US20100268047A1-20101021-C00003.png)
CH4975A4 (US20100268047A1-20101021-C00003.png)
CH51575A4 (US20100268047A1-20101021-C00003.png)
CH577919A5 (US20100268047A1-20101021-C00003.png)
CH596465A5 (US20100268047A1-20101021-C00003.png)
CH597968A5 (US20100268047A1-20101021-C00003.png)
CH585875A5 (US20100268047A1-20101021-C00003.png)
CH586557A5 (US20100268047A1-20101021-C00003.png)
CH586576A5 (US20100268047A1-20101021-C00003.png)
CH586954A5 (US20100268047A1-20101021-C00003.png)
CH589281A5 (US20100268047A1-20101021-C00003.png)
CH590956A5 (US20100268047A1-20101021-C00003.png)
CH590999A5 (US20100268047A1-20101021-C00003.png)
CH593044A5 (US20100268047A1-20101021-C00003.png)
CH591195A5 (US20100268047A1-20101021-C00003.png)
CH598315A5 (US20100268047A1-20101021-C00003.png)
CH585088A5 (US20100268047A1-20101021-C00003.png)

Legal Events

Date Code Title Description
ST Notification of lapse